skip to content

Verseon Corporation

16:57 on 17/11/2017

Current Price 120.00p | Bid 120.00p | Ask 130.00p | Change 0.00%

Company Overview

Verseon Corporation is a technology-based pharmaceutical company that employs its proprietary technology to design novel therapeutics for today's challenging diseases. The Company has applied its platform to three drug programmes in the areas of anticoagulation, diabetic macular oedema, and oncology. The pharmaceutical industry's trillion dollar revenue stream is facing enormous challenges. Traditional techniques for finding drug candidates are based on trial and error and are prone to failure. Only one out of three drug discovery programmes deliver a single drug candidate to the clinic, and, after another six to seven years in clinical trials and regulatory review, only one out of fifteen programmes result in a newly approved drug. Consequently, the industry has seen a severe downward trend in the number of new drugs coming to market despite having increased new drug R&D spending to over $115 billion per year. There is a pressing need for a more reliable, effective and scalable drug discovery process. The Company's platform seeks to overcome this bottleneck by consistently designing novel drug candidates that the Directors believe are unlikely to be found using conventional methods. It can design multiple novel drug chemotypes per programme, so there are several choices available for human clinical trials. A drug programme with multiple candidates is more likely to succeed in clinical trials and result in a useful therapy.

Stock Details

Shares in Issue 151,395,775
Market cap £ 243.75m
Sector Pharmaceuticals & Biotechnology
Indices FTSE AIM All-Share Index

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Price Summary

Mid Price ? 125.00p
Bid Price ? 120.00p
Ask Price ? 130.00p
Volume ? 0
Change Today 0.00p
% Change Today 0.00%
Open 0.00p
Previous Close 125.00p
Intraday High 0.00p
Intraday Low 0.00p
52 Week High 0.00p
52 Week Low 0.00p

Intra-Day Chart

More Charts »

Broker Consensus

The above information represents a selection of the views and target prices published in the last 120 days by analysts in individual stocks. It is subject to change without notice and may not necessarily be the view held by Redmayne-Bentley.

Client Area Access

» Secure Login

» Not registered yet?

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.